HomeCompareALPMF vs PG

ALPMF vs PG: Dividend Comparison 2026

ALPMF yields 3.14% · PG yields 2.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ALPMF wins by $25.95M in total portfolio value
10 years
ALPMF
ALPMF
● Live price
3.14%
Share price
$16.15
Annual div
$0.51
5Y div CAGR
83.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.00M
Annual income
$22,649,486.27
Full ALPMF calculator →
PG
Procter & Gamble
● Live price
2.92%
Share price
$144.73
Annual div
$4.23
5Y div CAGR
31.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.4K
Annual income
$9,955.44
Full PG calculator →

Portfolio growth — ALPMF vs PG

📍 ALPMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodALPMFPG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ALPMF + PG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ALPMF pays
PG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALPMF
Annual income on $10K today (after 15% tax)
$267.05/yr
After 10yr DRIP, annual income (after tax)
$19,252,063.33/yr
PG
Annual income on $10K today (after 15% tax)
$248.27/yr
After 10yr DRIP, annual income (after tax)
$8,462.12/yr
At 15% tax rate, ALPMF beats the other by $19,243,601.21/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALPMF + PG for your $10,000?

ALPMF: 50%PG: 50%
100% PG50/50100% ALPMF
Portfolio after 10yr
$13.02M
Annual income
$11,329,720.85/yr
Blended yield
86.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PG right now

ALPMF
No analyst data
Altman Z
2.8
Piotroski
7/9
PG
Analyst Ratings
29
Buy
22
Hold
1
Sell
Consensus: Buy
Price Target
$167.67
+15.9% upside vs current
Range: $150.00 — $179.00
Altman Z
5.3
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALPMF buys
0
PG buys
0
No recent congressional trades found for ALPMF or PG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricALPMFPG
Forward yield3.14%2.92%
Annual dividend / share$0.51$4.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR83.1%31.1%
Portfolio after 10y$26.00M$51.4K
Annual income after 10y$22,649,486.27$9,955.44
Total dividends collected$25.70M$29.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: ALPMF vs PG ($10,000, DRIP)

YearALPMF PortfolioALPMF Income/yrPG PortfolioPG Income/yrGap
1← crossover$11,275$575.25$11,003$382.92+$272.00ALPMF
2$13,174$1,109.91$12,205$520.11+$969.00ALPMF
3$16,316$2,219.21$13,674$712.22+$2.6KALPMF
4$22,161$4,703.07$15,507$985.02+$6.7KALPMF
5$34,643$10,931.15$17,847$1,378.96+$16.8KALPMF
6$66,310$29,241.64$20,913$1,959.19+$45.4KALPMF
7$166,730$95,777.84$25,044$2,834.00+$141.7KALPMF
8$590,501$412,100.01$30,786$4,189.46+$559.7KALPMF
9$3,129,389$2,497,553.06$39,052$6,357.54+$3.09MALPMF
10$25,997,932$22,649,486.27$51,429$9,955.44+$25.95MALPMF

ALPMF vs PG: Complete Analysis 2026

ALPMFStock

Astellas Pharma Inc. engages in the manufacture, marketing, import, and export of pharmaceuticals worldwide. It provides XTANDI, an androgen receptor signaling inhibitor for prostate cancer; XOSPATA, a FLT3 inhibitor for adult patients with relapsed or refractory acute myeloid leukemia with a FLT3 mutation-positive; PADCEV, a treatment solution for adult patients with locally advanced or metastatic urothelial cancer; Betanis/Myrbetriq/BETMIGA, a beta-3 adrenergic receptor agonist for the treatment of urgency, urinary frequency, and urge urinary incontinence; Evrenzo, an oral treatment for anemia associated with chronic kidney disease; and Prograf and Advagraf/Graceptor/ASTAGRAF, which are immunosuppressants used to suppress organ rejection following a transplant. The company also offers mirabegron for the treatment of neurogenic detrusor overactivity in pediatric patients; Vesicare for OAB treatment; Eligard to treat prostate cancer; Harnal/Omnic for benign prostatic hyperplasia treatment; and Funguard/MYCAMINE, an antifungal agent. The company has a clinical trial collaboration with Merck & Co., Inc.; CytomX Therapeutics, Inc.; and an agreement with BANDAI NAMCO Entertainment Inc. for the development of smartphone exercise support application. It also has strategic research alliance with Harvard University for the research and development of therapeutics and technologies of mutual interest; research collaboration with Actinium Pharmaceuticals, Inc. to develop targeted radiotherapies using its Antibody Warhead Enabling technology platform, as well as agreement with Zenith Epigenetics Ltd. to evaluate ZEN-3694; and collaboration agreement with Cytokinetics, Incorporated. The company has a strategic collaboration and license agreement with Minovia Therapeutics Ltd. for the research, development, and commercialization of cell therapy programs for diseases caused by mitochondrial dysfunction. Astellas Pharma Inc. was founded in 1923 and is headquartered in Tokyo, Japan.

Full ALPMF Calculator →

PGConsumer Staples

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Grooming segment provides shave care products and appliances under the Braun, Gillette, and Venus brand names. The Health Care segment offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brand names; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, pain relief, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. The Fabric & Home Care segment provides fabric enhancers, laundry additives, and laundry detergents under the Ariel, Downy, Gain, and Tide brands; and air care, dish care, P&G professional, and surface care products under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. The Baby, Feminine & Family Care segment offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and feminine care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. The company sells its products primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.

Full PG Calculator →
📬

Get this ALPMF vs PG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALPMF vs SCHDALPMF vs JEPIALPMF vs OALPMF vs KOALPMF vs MAINALPMF vs KMBALPMF vs CLALPMF vs CHD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.